First Capital Ventures, Inc.

www.firstcapitalventures.com

VCMatch tracks First Capital Ventures, Inc. as an investor focused on Digital Health, Healthtech, and Medtech companies, Series A and Growth rounds, United States and International markets, and $1m to $8m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$1m to $8m

Stages

Series A, Growth, Late Stage

Focus Areas

Digital Health, Healthtech, Medtech

Geography

United States and International

Investment Thesis

First Capital Ventures (FCV) follows a disciplined, selective, deal-by-deal investment philosophy focused on healthcare and healthcare-adjacent technologies. They prioritize rigorous technical, commercial, and financial diligence, bespoke transaction design and governance (via SPVs), and active partnership with entrepreneur teams — assuming risk alongside management while aiming to accelerate growth and commercialization within a relatively targeted liquidity horizon.

Is First Capital Ventures, Inc. right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

First Capital Ventures, Inc. is most relevant for founders raising Series A, Growth, and Late Stage rounds in Digital Health, Healthtech, Medtech, and Biotech, especially across United States and International, with public check-size signals around $1m to $8m.

Focus statement

FCV invests in healthcare and healthcare-related technologies with a current emphasis on digital health platforms, wellness technologies and healthcare-enabled innovation with scalable infrastructure, prioritizing technologies with clear commercial application and defined markets.

Value Add

Deal-by-deal structure: "Each investment is formed and governed through a dedicated SPV entity." This provides investor-level transparency versus a traditional blind-pool fund.
Large, experienced investor network: operates through "a network of approximately 150 accredited investors" who contribute operational, technical and leadership expertise alongside capital.
Transaction experience: provenance of "150+ financing transactions across domestic and international markets" and demonstrated role in sourcing, structuring and acting as financial advisor for portfolio companies.
Shorter, targeted liquidity horizon: explicitly seeks opportunities with a "targeted 24-36 month investment horizon" (shorter than typical 5–10 year VC horizons).
Active, hands-on partnership: positions itself as a "trusted partner" that provides both financial and strategic guidance and engages across the full investment lifecycle (sourcing, evaluation, structuring, capital formation, commercialization).
Proven technology focus and commercialization orientation: invests in technologies with "defined markets and commercial potential" and emphasizes building "acquisition-ready technologies" (e.g., Promptus activity).
Combines intellectual and financial capital: aims to "marry intellectual capital with investment capital" by leveraging advisors and experienced accredited investors in sourcing and diligence.